Compositions comprising HMG-CoA reductase inhibitor
The present invention relates to pharmaceutical compositions for sustained release comprising as active ingredient an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, said composition comprising an inner phase (internal) and an outer phase (external), wherein at least the o...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
09.09.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to pharmaceutical compositions for sustained release comprising as active ingredient an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, said composition comprising an inner phase (internal) and an outer phase (external), wherein at least the outer phase comprises at least one matrix former. |
---|---|
Bibliography: | Application Number: CN20038003031 |